Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Small Cell × pembrolizumab × Clear all

Phase

Status

Active not recruiting 2 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 29 Melanoma 20 Neoplasms 11 Breast Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Lung Neoplasms 9 Triple Negative Breast Neoplasms 8 Stomach Neoplasms 8 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Head and Neck Neoplasms 8 Pancreatic Neoplasms 7 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 6 Carcinoma 5 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Hodgkin Disease 4 Esophageal Neoplasms 4 Lymphoma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Glioblastoma 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Transitional Cell 3 Neoplasms, Squamous Cell 2 Mesothelioma 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2

Interventions

pembrolizumab 1 Temozolomide 1 Rhenium 1 Gemcitabine 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05368207 2024-03-13

Pemb-HT

University Health Network, Toronto

Phase NA Unknown

Ovarian Neoplasms, Carcinoma, Small Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡